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Control of the complement system is essential to prevent damage to autologous
tissue. Multiple proteins have been described that serve this regulatory function.
One group is focused at the C3 convertase stage ofthecomplement cascade, providing
critical control ofthe deposition ofC3 that can lead to clearance or lysis ofthemarked
particle or cell . This group includes serum (C4-binding protein [C4bp]t and factor
H [H])andmembrane proteins (C3b receptor [CR1], Cad/Epstein-Bare virus receptor
[CR2], decay-accelerating factor [DAF], and membrane cofactor protein [MCP]).
Each of these proteins binds to fragments o£C3 or C4, and may block formation
of the C3 convertase or serve as a cofactor for its proteolytic inactivation by serum
factor I (reviewed in references 1, 2) . This large number of proteins highlights the
importance of regulating complement activity. Furthermore, it has been suggested
that this might also be serving as a primitive self/non-selfimmunologic recogni
system (3) .
cDNAs for all ofthese proteins except MCP have been clonedand sequenced (4-12).
This has revealed a common structural motif-, each of the proteins is composed of
multiple repeats of an x+60-amino acid consensus unit composed of conserved cys,
pro, gly, trp, leu/ile/val, and tyr/phe residues (reviewed in reference 13) . The genes
for these five proteins have been localized to the long arm ofhuman chromosome
1, band lg32 (14-17) . Thus, these genes form a multigene family encoding complement-
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regulatory or receptor proteins, which we have designated the regulator of comple-
ment activation (RCA) gene cluster. Their common structural elements and close
genetic linkage suggest that they might all have arisen from an ancestral C3-binding
protein .
MCP was first identified in this laboratory by iC3/C3b affinity chromatography
on surface-labeled peripheral blood cells (and named gp 45-70 to describe its Mr
heterogeneity on SDS-PAGE) (18) . We subsequently purified the protein fromhuman
mononuclear cell lines and demonstrated that it possesses cofactor activity but no
decay-accelerating function (19) . We have found that MCP is present on human T
and B lymphocytes, granulocytes, monocytes, platelets, endothelial cells, epithelial
cells, and fibroblasts (18, 20-22) . Additionally, MCP occurs as a characteristic dou-
blet withMr of 63 and 58 x 10 3 on most of these cells, with a polymorphism gov-
erning the expression of these two bands (23) . C3b-binding molecules of similarMr
have been identified on rabbit alveolar macrophages (24) and on murine cells (25),
but their relationship to MCP has not been established .
Because ofits wide tissue distribution and cofactor activity, we have proposed that
MCP is an important membrane protein for protecting host cells from damage by
complement (3, 19, 22) . Its C3b binding and cofactor activity suggest that it should
belong to the complement-regulatory multigene family, but structural homology and
genetic linkage are necessary to place it within that group. In this report, we present
data to establish that position .
Materials and Methods
Protein Purification andNHzTerminal Sequencing.
￿
MCP protein was purified from the human
T cell line HSB2 by our previously reported procedure (19) using NP-40 solubilization fol-
lowed by sequential chromatography on chromatofocusing, hydroxylapatite, C3 (methyla-
mine)$epharose, and MonoQ columns. Approximately 20 Rg of protein was then run on
a SDS-10% polyacrylamide gel, electroeluted, and electrodialyzed as described (26) . This
material was divided in half and subjected to automated Edman degradation on polybrene-
coated glass filters in an Applied Biosystems, Inc . (Foster City, CA) model 470A sequencer
with a model 120A PTH analyzer.
Construction and Screening ofcDNA Library.
￿
RNA was isolated from the U937 cell line by
the quanidinium isothiocyanate/CsCl method (27) . Poly(A)' RNA was purified by
oligo(dT)-cellulose chromatography (28). A cDNA library was prepared from 5 ug poly(A)'
RNA by the method of Gubler and Hoffman (29) . cDNA inserts (size-selected >1.0 kb by
agarose gel electrophoresis) were ligated into Xgt10 arms, packaged, and plated on C600 hf1A
Escherichia coli. The library consisted of 2 .0 x 106 recombinants .
The oligonucleotide probe was synthesized on an Applied Biosystems, Inc . DNA synthesizer
(model 380A) bythe phosphoramidite method (30) . Failure sequences were removed byPAGE
and the probe was end-labeled with y_[32p]ATP. Duplicate plaque lifts on nitrocellulose filters
were hybridized overnight at 37°C in 6 x SSC (1 x SSC = 0.15 M sodium chloride/0.015
M sodium citrate)/5 x Denhardt's solution (1 x Denhardt's solution = 0.02% BSA/0.02%
Ficoll/0.02% polyvinylpyrrolidone)/0 .05 M sodium phosphate, pH 6.8, containing 100 ug
sonicated herring sperm DNA and 5 x 105cpm labeled probe per milliliter. The filters were
washed two times for 30 min with 2 x SSC/0 .1% SDS atroom temperature. Autoradiographs
were prepared at -70°C on Kodak X-Omit XAR film with Cronex intensification screens
(Dupont Co ., Wilmington, DE) . Plaques yielding positive signals in duplicate were plaque
purified by standard techniques (31) .
DNA Sequence Determination .
￿
Phage DNA was prepared and the cDNA inserts were sub-
cloned into the Eco RI site of pUC-19 by standard techniques (31) . DNA sequencing was
performed by dideoxy-chain termination (32) using alkaline-denatured, double-stranded DNALUBLIN ET AL.
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templates (33) and T7 polymerase(34; U. S. Biochemical Corp., Cleveland, OH). Sequencing
primers (used at -15:1 molar ratio to DNA templates) included forward and reverse M13
primers (New England Biolabs, Beverly, MA), as well as synthesized oligonucleotides corre-
sponding to already sequenced regions of the cDNA. Both strands were sequenced in their
entirety.
NorthernBlots.
￿
Total RNA, prepared as described above, was separated on formaldehyde/1%
agarose gels and transferred to nylon filters as described (31). These were hybridized over-
night at 42°C in 6x SSCAx Denhardt's solution/12 .5% dextran sulfate/0.1% SDSJ10 mM
Tris, pH 7.6/50% formamide containing 100 jig sonicated herring sperm DNA and 106 cpm
labeled probe per milliliter. cDNA probes were labeled with a-[32P]dCTP by random hex-
anucleotide priming (35). Hybridized filters were washed twice for 30 min at 56°C in 0.2 x
SSC/0.1% SDS and autoradiographs were prepared.
Somatic Cell Hybrids.
￿
Somatic cell hybrids were generated by polyethylene glycol 1000-
mediated fusion of human VA2 or IMR90 fibroblasts to Chinese E36 or Syrian BHK-B1
hamster cells that were mutant in their hypoxanthine-phosphoribosyltransfemse or thymi-
dine kinase genes, respectively, permittinghybrid cell selection with HAT. A panel for map-
ping studies was selected from a series of hybrids that contain the entire rodent genome but
that have selectively lost different combinations of human chromosomes. The human chro-
mosomal composition ofthe hybrid clones was determined by screening for up to 34 gene-en-
zyme systems (36), and in selected casesby complete cytogenetic analyses using trypsin-Giemsa
banding (37). High molecular weight DNA for Southern blots and cell homogenates for iso-
zymes were prepared from the same passages ofcells. DNA from the hybrid clones was digested
to completion with Eco RI or Hind III restriction endonucleases (New England Biolabs),
fractionated by electrophoresis through an agarose gel, transferred by Southern blotting to
nylon membranes, and hybridized with a 32P-labeled MCP cDNA probe prepared by the
random hexanucleotide priming method to a specific activity of 1-3 x 109 dpm/pg.
In Situ Chromosomal Hybridization.
￿
Human metaphase cells prepared from PHA-stimulated
peripheral blood lymphocytes were hybridized with 3H-labeled MCP cDNA probes. Radio-
labeled probes were prepared by nick translation of the entire plasmid with all four 3H-
labeled deoxynucleoside triphosphates to a specific activity of 108 dpm/pg. In situ hybridi-
zations were performed as described previously (38). Metaphase cellswere hybridized at 4.0
and 8.0 ng of probe per milliliter of hybridization mixture. Autoradiographs were exposed
for 11 d.
Results
cDNA Cloning .
￿
MCP protein was purified from the HSB2 T cell line as described
in Materials and Methods and subjected to automated Edman sequencing, yielding
the N112-terminal sequence through position 24 XEEPPTFEAMELIGKPKPYY
XIXE (standard single-letter codes; X, undetermined). A 64-fold degenerate 17-
mer antisense oligonucleotide probe based on amino acid residues 7-12 was used
to screen 1.3 x 105 recombinant plaques from the U937 cDNA library. One clone
giving a positive hybridization signal in duplicate was plaque purified, and the 1.5kb
insert was subcloned into the Eco RI site of pUC-19.
DNA Sequence.
￿
The DNA sequence ofthis cDNA clone was determined by dideoxy-
chain termination sequencing of both strands and contains a long open reading frame
encoding 384 amino acids beginning with an initiation methionine codon (Fig. 1).
The first 34 amino acids show the typical structure for a signal peptide (39) and
wouldpredict the signal peptide cleavage at the residue indicated in Fig. 1. The suc-
ceeding 24 amino acids exactly match the NH2-terminal protein sequence as de-
termined above for MCP, confirming the identification of this clone. This cDNA
encodes a polypeptide (without signal peptide) of 39 kD, which agrees with the size
ofthe MCP precursor detected in biosynthetic studies (40). Furthermore, there are184
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FIGURE 1 .
￿
Nucleotide and derived amino acid sequences ofMCP cDNA clone. The complete
nucleotide sequence of the MCPcDNA is displayed, numbered from the most 5' nucleotide .The
derived amino acid sequence,numbered from the firstamino acid of the mature protein, is shown
below using single-letter codes, with an asterisk denoting the stop codon . Three potential N-
glycosylation sites aremarked with arrows, an S/T-rich region is marked with a thin underline,
the hydrophobic transmembrane domain is marked with a heavy underline, and potential poly-
adenylation signals areboxed. These sequencedatahave been submittedto the EMBL/GenBank
Data Libraries under accession number Y00651 .
threepotential N-linked glycosylation sites, and multiple potential 0-linked glycosy-
lation sites in a ser/thr-rich region (12/25 residues) between amino acids 253-277 ;
this is consistent with the oligosaccharide structure of MCP, which contains 2-3
N-linked oligosaccharide units and multiple 0-linked units(40) . Aminoacids 278-294
representashort region ofunknown function . Hydrophobicity analysis (41) demon-
strates a 23-amino acid region typical for a transmembrane hydrophobic domain
at amino acids 295-317, followed by a 33-amino acid region corresponding to a
cytoplasmic tail . The 335-bp 3'-untranslated region ends in a 16-bp poly(A) track,
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FIGURE 3 .
￿
Northern blotanalysis ofMCPRNA . RNA was isolated from
cell lines, and 10 wg was separated by electrophoresis, transferred to nylon
filters, and hybridized with 32p-labeledMCP cDNA. The autoradiograph
showsRNA from Raji (lane 1), U937 (lane 2), and HeLa (lane 3) cells .
Migration ofthe 28Sand 18S bands is indicated. In addition tothe major
MCP species at 4 .2 kb, a minor band at 4 .8 kb is also present,
preceded 17 and 29 by upstream by the sequencesAATGAA andAATATA, respec-
tively, variants on the consensus polyadenylation signal AATAAA (42) .
The majority of the encoded MCP protein consists of four contiguous domains
of-60 amino acids, starting at theNH2 terminus, which match the consensus se-
quence found in the multigene family of complement-regulatory proteins (Fig . 2) .
These four domains show 18-35% amino acid homology to each other (29-44%
allowing conservative amino acid substitutions), similar to the degree ofhomology
found between these repeat units in other proteins of this family (13) .
Northern Blot Analysis .
￿
To determine the size (and number) ofmRNA species en-
coding MCP, Northern blots ofRNA from Raji, U937, and HeLa cell lines were
hybridized with the 32P-labeled MCP cDNA probe . The autoradiograph (Fig . 3)
shows the mainMCPmRNA at 4.2 kb in the latter two cells, which express MCP
protein . Raji cells, which possess no detectable MCP protein, do not show a band
on the Northern blot . This 1,546-bp cDNA clone contains 5'-untranslated sequence
and ends in a poly(A) track . The main 4.2-kbMCP message either possesses avery
long 5'-untranslated region, or, alternatively and more likely (see Discussion), this
FIGURE 4 .
￿
Hybridization of MCP-specific probe
toEco RI-digestedDNA from hamster x human
somatic cell hybrid clones . Hamster and human
DNAs are in lanes H and I, respectively. DNA
from hybrid clones containingchromosome 1 are
in lanes B, D, and F. DNA from hybrid clones
lacking chromosome 1 are in lanes A, C, E, and
G . Hybridization and Southern blotting were per-
formed as described in Materials and Methods .
Sizes are shown in kilobases .LUBLIN ET AL.
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TABLE I
Synteny Test of MCP Gene and Human Chromosomes in
Rodent x Human Hybrid Clones
Somatic cell hybrids were scored forthe presence ( + ) or absence ( - ) of specific
human chromosomes by assaying gene-enzyme systems and for the presence
or absence of MCP coding sequences by Southern blot hybridization.
cDNA and the 4.2-kbmRNA species represent products of differential polyadenyla-
tion or splicing.
Chromosomal Localization.
￿
Having found structural homology to the functionally
similar complement-regulatory proteins, we next wished to ascertain if there was
also a genetic linkage to this group. Therefore, we screened hamster-human somatic
cell hybrids for concordance of the MCP gene and specific human chromosomes.
Southern blots of Eco RI and Hind III digests of DNA from hamster-human
somatic cell hybrids were hybridized with the 12P-labeled MCP cDNA (a represen-
tative blot is shown in Fig. 4). This identified several Eco RI and Hind III fragments
from human DNA. The full panel of somatic cell hybrids was analyzed for discor-
dance of the MCP gene and specific human chromosomes, i.e., percent asynteny
(Table I). The MCP gene is located on chromosome 1; all other possible chromo-
some localizations were associated with a minimum of six discordant clones.
To confirm the association of MCP with chromosome 1 (using an independent
technique) and to sublocalize the MCP gene on chromosome 1, in situ hybridiza-
tions to normal human metaphase chromosomes were performed using two different
Human
chromo-
some +/+
MCP gene/human chromosome
+ / - - / + - / - Asynteny
1 17 0 0 16 0
2 6 8 2 13 34
3 0 6 1 5 58
4 4 5 2 8 37
5 8 6 10 5 58
6 10 5 11 4 53
7 2 7 1 4 57
8 6 8 10 7 58
9 12 3 9 6 40
10 4 3 4 7 39
11 10 1 11 3 48
12 7 4 10 8 48
13 8 3 10 3 54
14 10 4 10 7 45
15 7 7 9 5 57
16 7 1 6 1 47
17 13 1 12 1 48
18 1 6 0 7 43
19 7 7 10 5 59
20 5 4 7 4 58
21 1 6 0 4 55
22 0 6 0 5 55
X 4 2 10 5 57188
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FIGURE 5 .
￿
Distribution of labeled sites on
chromosome 1 in 100 normal metaphase cells
from PHA-stimulated peripheral blood lym-
phocytes that were hybridized with the full-
lengthMCPcDNA (A) orMCPBSCR cDNA
(B) probe . The MCPBSCR probe is a 650-
bp fragment of the full-length MCP cDNA
that lacks any ofthe sequence encoding the
60-amino acid short consensus repeat units .
The labeled sites observed in these hybridi-
zations were clustered at lg31-41 ; the largest
cluster of grains was located at lg32.
MCP probes . These hybridizations resulted in specific labeling of a single human
chromosome, namely chromosome 1 . All hybridizations were repeated twice and
they all gave similar results. In hybridizations performed with the full-lengthMCP
cDNA probe, we observed specific labeling of the distal long arm of chromosome
1 . Of 100metaphase cells examined from this hybridization, 37 (37%) were labeled
on region q3 or q4, bands q31-41, of one or both chromosome 1 homologs (1b <
0.0005) . The distribution of labeled sites on chromosome 1 is illustrated in Fig. 5
A. A total of 71 grains were observed on this chromosome ; of these, 51 (72%) were
clustered at bands q31-41 and represented 20.6% (51/248) of all labeled sites . The
largest cluster of grains was observed at lg32 .
TheMCP clone contains four copies ofthe homologous repeat unit characteristic
of the Cab-binding multigene family. Thus, this probe may crosshybridize to the
genes encoding other C3b-binding proteins, which have also been localized to this
region of chromosome 1 . To eliminate the possibility that the specific labeling of
lg31-41 observed in this hybridization was dueto crosshybridization tohomologous
repeat units of related genes, we hybridized the MCPBSCR probe to normal
metaphase cells . The latter probe is a 650-bp fragment ofthe full-lengthMCPcDNA
clone starting at the Sat I site at nucleotide 901, and does not contain the repeat
units . In this case, also, wenoted specific labeling only ofchromosome 1 . We exam-
ined 100 metaphase cells, and the distribution of labeled sites on this chromosome
is illustrated in Fig . 5B. Of these, 25 cells were labeled on region q3 or q4 (bands
q31-41) of one or both chromosome 1 homologs. A total of 41 grains was observed
on this chromosome; of these, 29 (71%) were clustered at bands lg31-41 and repre-
sented 17.1% (29/170) of all labeled sites (fi < 0.0005) . The largest cluster of grains
was observed at lg32 . Thus, the MCP gene is localized to human chromosome 1,
at bands q31-41 .
Discussion
Previouswork from this laboratory had shownthat purifiedMCP possesses cofactor
activity for inactivation ofC3b or C4b by serum factor I (19) . This would allow
MCP to regulate the complement system at the level of the C3 convertases, a role
shared by other members of the family of complement-regulatory proteins: CRl,
CR2, DAF, C4bp, and factorH . The present report of the complete primary struc-
ture and chromosomal localization ofhuman MCP establishes that it is indeed aLUBLIN ET AL.
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member ofthis multigene family, sharing structural homology and genetic linkage
as well as functional similarity to the other proteins.
The oligonucleotide probe used to identify the MCP cDNA clone was based on
amino acid residues 7-12 of purified MCP The identification of the clone was
confirmedwith 15 otheramino acidssurroundingthisregion. In addition, thepoly-
peptide encoded bythis cDNA clone matches several other properties for MCP: (a)
typical structure for a membrane protein, with a signal peptide at the NH2 ter-
minus, and aregion ofhydrophobic amino acids near the COOH terminus toserve
as the transmembrane domain; (b) overall size of 39 kD, in agreement with the
precursors (identified by anti-MCP antibody) seen in biosynthetic labeling experi-
ments (40); (c) three sites for N-linked glycosylation and multiple sites for 0-linked
glycosylation, consistent with the oligosaccharide structure of MCP (40); and (d)
tandemly arranged NH2-terminal homologous consensus repeat units characteristic
of other C3b/C4b-binding proteins. Taken together, these data indicate that this
cDNA clone encodes the full-length MCP polypeptide.
The most striking structural feature ofthe derived protein sequence for MCP is
the presence at the NH2 terminus of four contiguous repeats of a 60-amino acid
consensus sequence that has been found in other members of the complement-
regulatory multigene family as well as in other complement and noncomplement
proteins. This is the first structural data that links MCP to the other functionally
relatedcomplement-regulatory proteins. However, knowledgeofthe primary struc-
ture of this whole group of proteins has not shed light on the ligand binding site
or the functional domain for cofactor or decay-accelerating activity. Interestingly,
comparison of the different repeat units of MCP to the other proteins shows that
the highest homology match ofrepeat units two and three ofMCP is to these same
repeat units in CRl, C4bp, and H, as well as in C2 (43) and factor B (44, 45) of
the major histocompatibility complex, but to repeat units three and four of DAR
Overall, this would support speculation that these genes evolved from an ancestral
C3-binding proteinthatalreadypossessed atleasttwo repeat units. Genomiccloning
and sequence analysis will shed further light on this question in terms of the in-
tron/exon structure ofthe repeat units and a comparison ofthe intron sequences.
Northern blot analysis of RNA from U937, HeLa, and Raji cells shows a major
speciesof4.2 kb in the firsttwocelllines, butno MCP mRNAapparent in thelatter.
This correlates with the expression ofMCP protein in these cells. The discrepancy
betweenthesize ofthe mRNA andthecDNA clone must reflect additionaluntrans-
lated sequence at either the 5' or 3' end, or both. The difference of 2 kb would be
unusually large for a 5'-untranslated sequence, suggesting that this clone uses an
alternative, and earlier, polyadenylation signal than the major mRNA species. 17
and 29 nucleotides upstream of the poly(A) track are sequences (AATGAA and
AATATA, respectively) that support polyadenylation at levels <10% of wild type
(AATAAA) (42). Furthermore, the construction of the library with an oligo (dT)
primer and screening with a probe corresponding to the NH2 terminus ofthe pro-
tein would bias selection ofclones toward an earlier, minor polyadenylation signal.
This does not exclude the additional possibility of alternative RNA splicing, per-
haps leading to differences both in parts of the coding region as well as in the 3'-
untranslated region. Indeed, two forms ofMCP arefoundinmostcells (18, 23, 40).
Analysis of additional cDNA clones will be needed to elucidate this matter.190
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The multigene family of complement-regulatory proteins was first established by
our family studies that, by following protein polymorphisms, showed close genetic
linkage of CR1, C4bp, and H (14). Subsequently, another group used in situ chro-
mosomal hybridization with aCRI cDNA probe to map CR1 (and hencethelinkage
group of CR1/C4bp/H)to human chromosome 1, band lg32 (15). Theseinvestigators
also mapped CR2 to this location (15), and we and others have mapped the DAF
gene to this same location (16, 17). In the present study, we have used somatic cell
hybrid and in situ hybridization techniques to map MCP to human chromosome
1, band lg32. Because of the possibility of crossreaction of the MCPprobe to homol-
ogous sequences in the other genes, the in situ hybridizations were repeated with
aprobe that encodes none of the consensus repeat sequences; the chromosomal lo-
calization wasconfirmed. Thus, the multigenefamily ofcomplement-regulatory pro-
teins has been enlarged, now consisting of six members: CRI, CR2, DAF, MCP,
C4bp, and H.
Thelargenumber of related proteins in this multigenefamily might reflect speciali-
zation of these regulatory functions: membrane vs. serum proteins, classical vs. al-
ternative pathway control, and immune complex processing vs. protection of host
cells from autologous complement damage. In this regard, MCP and DAF seem
to form apair in serving the latter protective function. MCP and DAF show a very
similar structure (Fig. 6): membrane proteins with four NH2-terminal consensus
repeat units, followed by aser/thr-rich region (probable site ofheavy0-linked glycosy-
lation), and then a hydrophobic domain. This latter domain is replaced by a
glycophospholipid membrane anchor in DAF (46, 47), but forms a transmembrane
polypeptide anchor followed by a cytoplasmic domain in MCP DAF functions in-
trinsically to protect host cellsfrom amplificationofthecomplement cascadeon their
surfaces (48, 49); the similar size, structure, and properties of MCP suggest that
it might also function in this role (3). Indeed, DAF and MCP have complementary
functions for preventing complement amplification, the former possessing decay-
accelerating properties and the latter cofactor activity. Expression of either MCP,
DAF, or both in transfected cellswill allowthe role oftheseproteins to be addressed.
Summary
Membrane cofactor protein (MCP), a regulatory molecule of the complement
system with cofactor activity forthe factor I-mediated inactivation ofC3b andC4b,
is widely distributed, being present on leukocytes, platelets, endothelial cells, epi-thelial cells, and fibroblasts. MCP was purified from a human T cell line (HSB2)
and the NH2-terminal 24-amino acid sequence obtained by Edman degradation.
An oligonucleotide probe based on this sequence was used to identify a clone from
a human monocytic (U937) cDNA library. Nucleotide sequencing showed a 43-bp
5'-untranslated region, an open reading frame of 1,152 bp, and a 335-bp 3'-untranslated
region followed by a 16-bp poly(A) track. The deduced full-length MCP protein
consists of a 34-amino acid signal peptide and a 350-amino acid mature protein.
The protein has, beginning at the NH2 terminus, four -60-amino acid repeat units
that match the consensus sequence found in a multigene family of complement regula-
tory proteins (C3b-receptor or CRl, C3d-receptor or CR2, decay-accelerating factor,
C4-binding protein, and factor H), as well as several other complement and non-
complement proteins. The remainder ofthe MCP protein consists of25 aminoacids
that are rich in serine and threonine (probable site of heavy O-linked glycosylation
of MCP), 17 amino acids ofunknown significance, and a 23-amino acid transmem-
brane hydrophobic region followed by a 33-amino acid cytoplasmic tail. The MCP
gene was localized to human chromosome 1, bands lg31-41, by analysis of human
x rodent somatic cell hybrid clones and by in situ hybridization. This same genetic
region contains the multigene family of complement-regulatory proteins, which is
thereby enlarged to include the functionally and structurally related MCP
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